Molecular and Immunophenotypic Modulation Induced by Radiotherapy in Breast Carcinoma

.blurhash-client-img { display: none !important; }

Open Access

|Dec 2025

References

Allison, K. H., et al. (2020). Estrogen and progesterone receptor testing in breast cancer: ASCO/CAP update. JCO, 38(12), 1346–1366.
Search in Google Scholar Back to article
Fenton, S. E., et al. (2025). Radiation and immunotherapy synergy in HR+ breast cancer. npj Breast Cancer, 11(1), 88.
Search in Google Scholar Back to article
Lee, S., et al. (2023). Epigenetic reprogramming after radiotherapy. Cancers, 15(4), 1213. Michmerhuizen, N. L., et al. (2022). ER inhibition mediates radiosensitization. Front Oncol, 12, 849245.
Search in Google Scholar Back to article
Zhang, Y., et al. (2024). Radiation-induced phenotype switching in breast carcinoma. Breast Cancer Res, 26(3), 44.
Search in Google Scholar Back to article

DOI: https://doi.org/10.2478/bjir-2025-0029 | Journal eISSN: 2411-9725 | Journal ISSN: 2410-759X

Language: English

Page range: 132 - 134

Published on: Dec 12, 2025

Published by: International Institute for Private, Commercial and Competition Law

In partnership with: Paradigm Publishing Services

Publication frequency: 3 issues per year

Keywords:

Related subjects:

© 2025 Siltana Zeneli, published by International Institute for Private, Commercial and Competition Law
This work is licensed under the Creative Commons Attribution-NonCommercial 4.0 License.